Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
48,003,054
-
Share change
-
-1,053,738
-
Total reported value
-
$1,971,835,206
-
Put/Call ratio
-
96%
-
Price per share
-
$41.08
-
Number of holders
-
164
-
Value change
-
-$47,514,370
-
Number of buys
-
81
-
Number of sells
-
69
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q2 2019
As of 30 Jun 2019,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,003,054 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FARALLON CAPITAL MANAGEMENT LLC, STATE STREET CORP, Artal Group S.A., WELLINGTON MANAGEMENT GROUP LLP, GREAT POINT PARTNERS LLC, and JANUS HENDERSON GROUP PLC.
This page lists
164
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.